SCHEMBL13634396

SCHEMBL13634396

CCOC1CN(c2nccs2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CHRM2 P08172 2/20 0.39
CHRM1 P11229 2/20 0.39
CHRM3 P20309 2/20 0.39
PIK3CD O00329 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 1/20 0.36
KDM4C Q9H3R0 1/20 0.35
HPGD P15428 1/20 0.35
GRM5 P41594 1/20 0.35
GRM1 Q13255 1/20 0.35
HTT P42858 1/20 0.35
CHI3L1 P36222 2/20 0.35
POLB P06746 1/20 0.35
APEX1 P27695 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13634337 0.88 PIK3CD (0.48) NPC1RAB9ACHRM2CHRM1CHRM3
SCHEMBL3570802 0.81 NPC1 (0.49) NPC1RAB9APIK3CDHRH3MEN1
SCHEMBL28662898 0.75 NPC1 (0.40) NPC1RAB9APIK3CDHRH3MEN1
SCHEMBL13634414 0.73 HRH3 (0.40) NPC1RAB9AHRH3MEN1KMT2A
SCHEMBL19080603 0.73 HPGD (0.44) NPC1RAB9AHRH3DRD2MEN1
SCHEMBL2640732 0.72 KDM4C (0.44) NPC1RAB9AHRH3MEN1ALDH1A1
SCHEMBL2857147 0.72 NPC1 (0.41) NPC1RAB9AHRH3DRD2MEN1
SCHEMBL30461783 0.72 DPP4 (0.43) NPC1RAB9ADRD2MEN1ALDH1A1
SCHEMBL3160083 0.71 NPC1 (0.42) NPC1RAB9AHRH3MEN1KMT2A
SCHEMBL3160078 0.71 NPC1 (0.42) NPC1RAB9AHRH3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179061-A1 RIP1 MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2025-06-05 US disclosed
WO-2023160638-A1 RIP1 MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-08-31 WO disclosed
US-8304547-B2 Azolecarboxamide compound or salt thereof ASTELLAS PHARMA INC. (JP) 2012-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250179061-A1 RIP1 MODULATORS, PREPARATIONS, AND USES THEREOF RIPK1, RIPK2, RIPK3 NPC1 1190/4885RAB9A 814/4885CHRM2 3831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.